Pharmafile Logo

Kath Kerry

- PMLiVE

Roche reveals promising phase 3 results for subcutaneous Ocrevus in progressive and relapsing MS

The chronic neurological condition affects more than 2.8 million people worldwide

- PMLiVE

Novartis presents positive long-term data for relapsing MS treatment Kesimpta

Approximately 85% of MS patients are initially diagnosed with relapsing forms of the neurological disease

- PMLiVE

UK scientists reveal promising new treatment strategy for acute myeloid leukaemia

The aggressive form of blood cancer is responsible for more than 3,000 new cases in the UK every year

- PMLiVE

AstraZeneca study reveals increasing number of people impacted by chronic kidney disease

CKD is a progressive condition that affects nearly 850 million people worldwide

- PMLiVE

Women’s health – managing the menopause

PME spoke to Marci English, Vice President and Head of BioPharma Development, Astellas, about the importance of new treatments for menopause symptoms, the unmet need and the company’s commitment to...

- PMLiVE

Roche receives FDA breakthrough device designation for Alzheimer’s disease blood test

Around 55 million people globally are living with dementia, which is estimated to rise to 139 million by 2050

- PMLiVE

Sanofi presents promising results for investigational frexalimab in relapsing forms of MS

Approximately 85% of patients are initially diagnosed with relapsing forms of the neurological disease

- PMLiVE

Novartis shares positive late-stage results for Fabhalta in rare kidney disease IgA nephropathy

Approximately 25 people per million worldwide are diagnosed with IgAN every year

- PMLiVE

Havas Life Medicom and Sciterion appoint Dick Dunford as group creative director

Dunford recently served as executive creative director at TBWA\WorldHealth

Navigating-Stress-in-the-wrokplace

Navigating Stress: Understanding, Addressing, and Supporting Our Team

Explore how we're supporting our team with managing stress in the workplace

Mednet Group

- PMLiVE

Research conducted for Johnson and Johnson published in scientific journal

Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.

Research Partnership

- PMLiVE

Why choose a B Corp agency?

Going through the B Corp process – and successfully gaining certification at the end of last year – gave us a stronger sense of our values as an agency. It...

Wallace Health

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links